Mode
Text Size
Log in / Sign up

In UK primary care, the NAT-C tool guided consultations resulted in clinical action for 72% of cancer consultationsWhy a Simple Cancer-Care Tool Works in Theory but Stalls in Real GP Offices

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that 72% of NAT-C consultations resulted in clinical action, but implementation requires resources and champions.

This study utilized a cluster randomized controlled trial design with a mixed-methods process evaluation component. The population consisted of people with cancer, excluding those in remission, across 21 general practices in England. The intervention involved using the Needs Assessment Tool-Cancer (NAT-C) to guide consultations, compared against usual care. A total of 360 consultations were delivered, representing 96% of the 376 planned consultations.

Regarding secondary outcomes, 258 of the 360 consultations (72%) resulted in some form of clinical action. Additionally, 50 consultations (13%) resulted in external referrals. Process evaluation surveys were conducted before and after intervention delivery. Initial surveys (n=53) showed positive responses across all Normalization Process Theory (NPT) domains. Follow-up surveys (n=29, representing 14 paired before-and-after responses) indicated that participants continued to view the tool as relevant and useful. However, these participants highlighted concerns about insufficient resources and a lack of management support for implementation.

No adverse events, serious adverse events, discontinuations, or specific tolerability issues were reported. The study limitations include the absence of reported p-values or confidence intervals for the primary outcomes and the lack of reported limitations in the text. The study was not designed to establish clinical efficacy or causal impact on patient health outcomes. Generalizability beyond the UK primary care setting is uncertain. Practice relevance suggests that successful implementation requires champions, clinician buy-in, and essential resources, though financial incentives were viewed with mixed feelings.

The check-in cancer patients often don't get

When someone is diagnosed with cancer, the focus is naturally on the hospital — surgery, chemotherapy, oncology appointments. But much of life with cancer happens between those visits.

Most patients return to their family doctor for support, prescriptions, and unrelated health needs. Whether those visits surface bigger unmet needs — emotional, financial, practical — depends on whether anyone thinks to ask.

A new study tested a simple tool designed to make sure those asks happen.

Cancer survivors and people in active treatment often carry a long list of unmet needs. Pain that hasn't been fully addressed. Mental health struggles. Financial strain. Caregiver burden. Side effects nobody's noticed yet.

GPs are well-positioned to spot these issues, but visits are short and packed. Without a structured prompt, important needs can slip past — even when both patient and doctor want to address them.

The Needs Assessment Tool — Cancer, called NAT-C, is a structured guide designed to surface those needs in a single, focused consultation. The question this study asked is whether GPs actually use it, what gets in the way, and what makes it stick.

The old way versus the new way

In typical practice, identifying unmet needs depends on the patient bringing them up or the doctor noticing in passing. Both work some of the time. Neither is reliable.

NAT-C creates a defined consultation. The GP works through a structured set of prompts covering physical, psychological, social, and information-related needs. Each identified concern is triaged — handled in the visit, referred elsewhere, or scheduled for later follow-up.

It's the equivalent of a check-engine review for cancer-related issues, designed to catch what would otherwise be missed.

How the implementation study worked

Imagine introducing a new safety checklist to a busy restaurant kitchen. Whether it gets used depends on more than just the checklist itself. The chef has to believe in it. The staff need to be trained. There has to be time built into the workflow.

That's the framework behind this evaluation. The researchers used a theory called normalisation process theory to look not just at whether NAT-C consultations happened, but at the human and organizational factors that made them stick or fall away.

They surveyed clinicians before and after using the tool, interviewed practitioners and key stakeholders, and tracked how each consultation translated into clinical action.

The study snapshot

The team analyzed a process evaluation embedded within a UK trial of NAT-C. Twenty-one general practices were involved, with clinicians trained to deliver structured needs-assessment consultations. Researchers measured fidelity (how well the consultations followed the protocol), tracked downstream actions, surveyed clinicians at two time points, and conducted in-depth interviews with 16 participants — eight GPs and eight key stakeholders.

Clinicians delivered the consultation faithfully in 96% of cases. Of the 360 consultations, 72% led to a specific clinical action. About 13% prompted external referrals to other services.

Surveys before delivery showed enthusiasm. After delivering several consultations, that enthusiasm cooled. While clinicians still saw the tool as relevant and useful, they raised concerns about the time, IT systems, and management support needed to keep it going.

The interviews surfaced five themes. First, the tool's perceived value to patients was the strongest driver of use. Second, "champions" — people who actively promoted the tool at the practice, regional, and national level — mattered enormously. Third, research evidence influenced uptake mostly indirectly, through policy and clinical guidelines. Fourth, resources were essential to embed the tool beyond enthusiastic individuals. Fifth, the practical mechanics — including IT — had to work smoothly.

Even a useful tool fails without the local conditions to support it.

Where this fits in the bigger picture

Implementation gaps are one of the most stubborn problems in modern healthcare. Many tools, guidelines, and protocols have been shown to help in trials, only to fade in real-world use because the systems around them weren't ready.

This study is a careful look at why. The same patterns appear across cancer care, mental health, chronic disease management, and beyond. Champions matter. Time matters. IT matters. Without those, even the best tool gets shelved.

If you or a family member is living with cancer and seeing your GP regularly, you can ask whether the practice uses any kind of structured needs assessment. If not, you can still bring up specific concerns yourself — physical symptoms, mental health, money worries, caregiver stress, information gaps. Naming them gives the GP a chance to act on them.

Coming to a visit with a short written list of concerns — even just three or four items — often surfaces issues that wouldn't otherwise come up in a 10-minute visit.

This was a process evaluation focused on implementation, not on patient outcomes. It can tell us how well the tool was used and what stood in the way, but not whether it improved survival, mental health, or quality of life. The findings come from one country's primary care system, which may differ from others. The clinicians who joined the study likely had above-average interest in cancer care.

The full trial of NAT-C will report on whether the tool actually improved outcomes for cancer patients in primary care. If it did, the next challenge is the very implementation problem this study describes — turning a useful tool into routine practice. That likely requires policy support, financial backing, and integration into existing electronic health records.

Study Details

Study typeRct
Sample sizen = 53
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: The Needs Assessment Tool-Cancer (NAT-C) is a consultation guide to identify, triage and reduce unmet patient needs. OBJECTIVES: We aimed to assess NAT-C fidelity, mechanisms of action and implementation issues in UK primary care as part of a clinical and cost-effectiveness cluster randomised controlled trial of the NAT-C for people with cancer compared with usual care (registration: ISRCTN15497400). METHODS: Design: a mixed-methods process evaluation informed by normalisation process theory (NPT). SETTING: 21 participating general practices in England were randomised to be trained to conduct an NAT-C guided consultation with people with cancer (excluding those in remission). General practitioner fidelity of intervention and clinical action resulting from the NAT-C consultation was noted. Two Normalisation MeAsure Development Questionnaire surveys were distributed to trained clinicians before (Survey 1) and after delivery of ≥2 NAT-C consultations (Survey 2). Semi-structured interviews were conducted with clinicians (post delivery ≥2 NAT-C consultations) and key stakeholders in primary and cancer care. Fidelity, action and paired before/after survey data were analysed using descriptive statistics. Interview data were analysed using a deductive thematic framework approach (NPT-informed). Data were narratively synthesised with cross-tabulated key findings. RESULTS: Of the 360/376 (96%) NAT-C consultations delivered, 258/360 (72%) resulted in clinical action, including 50 (13%) external referrals. 14 paired before (Survey 1, n=53) and after (Survey 2, n=29) responses. Survey 1 showed positive responses across all NPT domains, but while continuing to see relevance, usefulness and legitimacy, Survey 2 highlighted concerns about insufficient resources and management support. 16 clinician participants (eight GPs, eight key stakeholders; 50% male) completed interviews. Following synthesis, we identified five themes: (1) the perceived value of the NAT-C; (2) 'champions' are important at all levels (practice, regionally and nationally); (3) research evidence is seen as important, but influences implementation indirectly through policy, clinical guidelines and resourced initiatives; (4) adequate resources are fundamental for implementation beyond practice level and (5) NAT-C practicalities; training is adequate, but robust functional information technology systems are needed. CONCLUSION: Implementation requires champions and clinicians 'buy-in' to the patient value to legitimise use. In the context of current primary care pressures, resources were seen as essential to embed the NAT-C, but financial incentives were viewed with mixed feelings. TRIAL REGISTRATION NUMBER: ISRCTN15497400.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.